Test Price
2,800 AED✅ Home Collection Available
MXRA5 Gene Autism Spectrum Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل الجين MXRA5 المرتبط باضطراب طيف التوحد عبر الجيل التالي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
يضمن مختبرنا المعتمد من هيئة الصحة بدبي (DHA) دقة تشخيصية بنسبة 99.9% وفقًا لمعايير ISO 9001:2015 لتقديم نتائج موثوقة وسريرية شاملة لتحليل MXRA5.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The MXRA5 Gene Genetic Test analyzes the MXRA5 gene for variants linked to autism spectrum disorder (ASD), providing a definitive molecular diagnosis.
تحليل تسلسل الجين MXRA5 باستخدام تقنية NGS يوفر تشخيصًا جزيئيًا دقيقًا لاضطراب طيف التوحد عبر تحديد الطفرات الجينية.
| Feature | Our MXRA5 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | Targeted gene with deep coverage; 99.9% sensitivity for MXRA5 variants | Broad genomic survey; lower depth per gene, may miss intronic regulatory variants |
| Method | Next‑Generation Sequencing (NGS) with Sanger confirmatory validation | NGS‑based whole exome capture; incidental findings possible |
| Speed | 3 to 4 Weeks | 6 to 8 Weeks (often requires multiple follow‑ups) |
Physician Insight & Safety Protocol
“As a Consultant Neurologist, I emphasize that this genetic test aids in understanding the etiology of ASD, but clinical correlation with behavioral assessments is essential. If the result indicates a pathogenic variant, it may inform prognosis and family planning, but does not replace comprehensive neurodevelopmental evaluation.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active severe bleeding disorders precluding safe venipuncture; inability to provide blood or FTA card sample; lack of informed consent from legal guardian (for minors).
- Exclusion Criteria: For minors, mandatory pre‑test genetic counselling and parental/legal guardian consent as per UAE CDS Law 2026.
- Emergency Red Flags: If after sample collection the patient experiences sudden severe behavioral changes, new‑onset seizures, or signs of anaphylaxis, seek immediate emergency medical care.
- Emergency Red Flags: Any unexpected severe pain, swelling, or hematoma at the venipuncture site that expands rapidly.
Patient FAQ & Clinical Guidance
1. What is the MXRA5 gene test used for?
The MXRA5 genetic test detects pathogenic variants in the MXRA5 gene linked to autism spectrum disorder, providing a precise molecular diagnosis. يكشف تحليل MXRA5 عن الطفرات المسببة لاضطراب طيف التوحد لتأكيد التشخيص الجزيئي. This test is indicated when clinical features suggest a monogenic cause of autism, and results can guide therapeutic and educational interventions. It is often recommended for children with complex ASD presentations or a positive family history of neurogenetic disorders.
2. How is the test performed and what sample is required?
We accept whole blood, extracted DNA, or a blood spot on an FTA card, collected at home by licensed phlebotomists. نقبل عينة دم كامل أو حمض نووي مستخلص أو بقعة دم على بطاقة FTA، تُجمَع في المنزل بواسطة فنيين مرخصين. A hospital‑grade home collection team arrives within your chosen window (8 AM – 11 PM), ensuring cold‑chain transport to our ISO‑certified laboratory. No special preparation is required, but a pre‑test genetic counselling session is mandatory to document clinical history and family pedigree.
3. What do the results mean and how fast will I receive them?
Results are reported within 3 to 4 weeks and classify the variant as pathogenic, benign, or of uncertain significance. تصدر النتائج خلال 3 إلى 4 أسابيع وتصنف الطفرة كمرضية أو حميدة أو غير محددة الأهمية. A pathogenic finding confirms a genetic basis for ASD, which can inform prognosis, early intervention strategies, and family recurrence risk. Variants of uncertain significance will be discussed in a telephonic post‑ clinical guidance session with our neurologist. All data is handled in strict compliance with UAE PDPL and Federal Decree‑Law No. 41 of 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians